# Sutro Biopharma, Inc.: Form 8-K, filed Mar 13, 2025

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2025-03-13
- Accepted by EDGAR: Mar 13, 2025, 17:14 ET
- Period: 2025-03-13
- Accession: 0000950170-25-038879
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000095017025038879/stro-20250313.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000095017025038879/

## Items reported

- Item 2.02: Results of operations
- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000095017025038879/stro-20250313.htm

Filed Mar 13, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-038879. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.